$68.98
+3.63 (+5.55%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-35.1% upside
Low Target
$31.89
Average Target
$44.79
High Target
$48.55
Current Price
$68.98
Current
$68.98
$68.98
Target
$44.79
$44.79
$31.89
$44.79 avg
$48.55
Scenario Analysis
Bear Case
$31.89
-53.8%
Low target
Base Case
$44.79
-35.1%
Avg target
Bull Case
$48.55
+-29.6%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$240.00
-71.3% from high
52-Week Low
$4.28
+1,511.7% from low
Target vs 52W High
$44.79
-81.3% vs high
Next Earnings Report
Apr 13, 2026 · After Market Close
10d
until earnings
EPS Est: $-8.15
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.8% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.0% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +158.5% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.0% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -13.0% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.7% |